Sclerosis Clinical Trials in Chicago, Illinois

51 recruitingChicago, Illinois

Showing 120 of 51 trials

Recruiting
Phase 1

A Study of AZD0120 in Autoimmune Diseases

Rheumatoid ArthritisIdiopathic Inflammatory MyopathiesSystemic Sclerosis
AstraZeneca27 enrolled18 locationsNCT07295847
Recruiting
Phase 3

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

Relapsing Multiple Sclerosis
Novartis Pharmaceuticals360 enrolled99 locationsNCT06846281
Recruiting
Phase 3

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting
Bristol-Myers Squibb194 enrolled33 locationsNCT06408259
Recruiting
Phase 1

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmRheumatoid Arthritis+11 more
National Cancer Institute (NCI)300 enrolled52 locationsNCT03816345
Recruiting
Phase 4

Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis

Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)123 enrolled12 locationsNCT05285891
Recruiting

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Multiple SclerosisRelapsing Multiple Sclerosis
TG Therapeutics, Inc.500 enrolled85 locationsNCT06433752
Recruiting
Not Applicable

Intermittent Hypoxia in Persons With Multiple Sclerosis

Multiple Sclerosis
Shirley Ryan AbilityLab21 enrolled1 locationNCT06276634
Recruiting

People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

Multiple Sclerosis
Northwestern University100 enrolled1 locationNCT07207148
Recruiting
Phase 4

Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis

Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remitting
Northwestern University40 enrolled1 locationNCT07225361
Recruiting
Phase 3

Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis

Multiple Sclerosis
Sanofi900 enrolled338 locationsNCT06141486
Recruiting
Not Applicable

Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS

Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary Progressive
Shirley Ryan AbilityLab22 enrolled1 locationNCT06390930
Recruiting
Phase 2

Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study

EpilepsyTuberous Sclerosis Complex
Darcy Krueger64 enrolled11 locationsNCT05104983
Recruiting
Not Applicable

Home Based Functional Balance Intervention for Multiple Sclerosis

Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (MS) Primary Progressive+2 more
University of Illinois at Chicago75 enrolled1 locationNCT07355387
Recruiting
Not Applicable

Internet-Delivered Lifestyle Physical Activity Intervention for Cognitive Processing Speed in Multiple Sclerosis

Multiple Sclerosis
University of Illinois at Chicago280 enrolled1 locationNCT04518657
Recruiting

Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures

Movement DisordersAmyotrophic Lateral SclerosisDegenerative Disorder+1 more
Target ALS Foundation, Inc.1,000 enrolled12 locationsNCT05137665
Recruiting
Early Phase 1

Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues

ObesityMultiple SclerosisLong COVID+4 more
University of Chicago30 enrolled1 locationNCT06171152
Recruiting
Not Applicable

Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis

Multiple SclerosisMajor Depressive Disorder
University of Illinois at Chicago146 enrolled1 locationNCT05051618
Recruiting
Not Applicable

Effects of High-intensity Gait Training on Fatigue, Gait, and Neuroplasticity in People With Multiple Sclerosis

Multiple Sclerosis
University of Illinois at Chicago20 enrolled1 locationNCT06264336
Recruiting
Not Applicable

Remote Therapeutic Monitoring Exercise Tracking

Multiple SclerosisParkinson Disease
Shirley Ryan AbilityLab200 enrolled1 locationNCT06306768
Recruiting
Not Applicable

Functional Balance Intervention in Multiple Sclerosis

Multiple Sclerosis
University of Illinois at Chicago120 enrolled1 locationNCT06341023